Right-To-Try, Biosimilar Substitution, Fail-First Policy Among New State Drug Policy Laws

By John Wilkerson / June 5, 2017 at 3:46 PM
At least 33 states this year enacted 104 laws that affect prescription drug policy, according to an interim report by the National Conference of State Legislatures. Common themes in the sample of new laws compiled by the National Conference on State Legislatures include right-to-try, restrictions on plans and pharmacy benefit managers, and biologics substitution. Lobbyists for drug makers, plans and pharmacy benefit managers are working hard to blame one another for rising drug prices. Some states, including New York ,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.